Jae Seok Bae
서울대학교 의과대학 방사선학과 · 의학
Jae Seok Bae 교수의 연구실은 간세포질환, 특히 간세포생식성암(HCC)의 정밀 진단과 치료 평가를 중심으로 한 영상의학 연구를 전개하고 있습니다. 고해상도 MRI, 혈관 영상 기법(MFI, PDI 등) 및 LI-RADS 기반 영상 분석을 활용해 간암의 혈관성 소견, 간문맥 혈전증, 종양 침습 여부를 정밀하게 평가하고 있으며, 특히 수술 또는 간이식 후 병리 결과와의 비교를 통해 영상 진단의 정확도를 높이는 데 초점을 맞추고 있습니다. 또한 위식도 기능 이상에 대한 내시경적 치료 전략에 대해서도 임상적 유효성과 안전성을 검증하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
The sensitivity of MFI was higher than that of CDI or PDI in detecting the vascularity of HCCs when the vascular pattern was considered. MFI better detected the vascularity of shallow tumors.
For detecting HS ≥5%, MRI-PDFF was the best imaging modality, while ATI outperformed grayscale US. For detecting HS >33%, all five imaging tools demonstrated good diagnostic performance.
GA-MRI detected PVTT more often than CECT in HCC patients meeting the Milan criteria and better depicted PVTT in continuity with tumors and those showing enhancement than CECT.
Background The Liver Imaging Reporting and Data System (LI-RADS), version 2018, treatment response algorithm (TRA) is used to assess hepatocellular carcinoma (HCC) after local-regional therapy (LRT). However, its diagnostic performance has not yet been fully compared between CT and hepatobiliary agent (HBA)-enhanced MRI in patients who have undergone liver transplant (LT). Purpose To compare the diagnostic performance of LI-RADS TRA when using CT versus using HBA-enhanced MRI in an intraindividu
Background Diagnostic performance of the Liver Imaging Reporting and Data System tumor in vein (LR-TIV) category at CT and/or MRI has not yet been evaluated, to the knowledge of the authors. Purpose To assess the diagnostic performance of the LR-TIV category in detecting macroscopic tumors in veins (TIVs) at CT and hepatobiliary contrast agent-enhanced (HBA) MRI, with pathologic results used as the reference standard. Materials and Methods Between January 2010 and December 2019, consecutive pati
Balloon dilation is a safe and effective treatment for patients with pyloric spasms after PPG. In patients refractory to balloon dilations, retrievable stent placement can be a safe alternative tool.